Table 3 The comparison of metabolites between PW children with and without prematurity during the follow-up
From: Metabolomics of bronchoalveolar lavage in children with persistent wheezing
| Â | PW children (median, 25%, 75%) | PW with recurrence (median, 25%, 75%) | ||||
|---|---|---|---|---|---|---|
Metabolites | Term infants (n = 21)# | Preterm infants (n = 9)# | P value | Term infants (n = 12) | Preterm infants (n = 5) | P value |
Choline | 132.77 (80.11, 176.97) | 122.17 (84.08, 145.63) | 0.874 | 135.90 (84.84, 172.05) | 84.15 (68.01, 126.01) | 0.292 |
Oleamide | 0.30 (0.11, 1.10) | 0.30 (0.14, 2.44) | 0.769 | 0.23 (0.13, 1.64) | 0.21 (0.05, 1.73) | 0.598 |
Nepetalactam | 0.08 (0.02, 0.92) | 0.06 (0.00, 1.02) | 0.946 | 0.31 (0.04, 1.02) | 0.20 (0.002, 2.26) | 0.833 |
Butyrylcarnitine | 0.54 (0.25, 1.04) | 1.20 (0.61, 1.91) | 0.025* | 0.47 (0.19, 0.78) | 1.20 (0.68, 2.80) | 0.027* |
l-Palmitoylcarnitine | 0.02 (0.01, 0.087) | 0.02 (0.01, 0.08) | 0.874 | 0.01 (0.005, 0.09) | 0.02 (0.005, 0.11) | 0.833 |
PC(16:0/16:0) | 36.69 (16.44, 52.23) | 33.73 (6.05, 56.49) | 0.769 | 45.68 (13.06, 52.75) | 7.21 (4.31, 31.01) | 0.092 |
Palmitoylethanolamide | 0.18 (0.07, 0.75) | 0.31 (0.11, 1.94) | 0.512 | 0.16 (0.05, 1.34) | 0.15 (0.04, 1.48) | 0.916 |
PC(22:2(13Z, 16Z)/14:0) | 2.05 (0.90, 10.11) | 1.48 (0.86, 7.51) | 0.874 | 1.90 (0.67, 13.63) | 0.92 (0.60, 9.18) | 0.461 |
PC(16:0/14:0) | 2.84 (0.58, 5.18) | 1.44 (0.50, 29.06) | 0.946 | 3.49 (0.94, 42.45) | 1.44 (0.99, 20.16) | 0.752 |
PC(22:4(7Z, 10Z, 13Z, 16Z)/14:0) | 0.86 (0.62, 2.94) | 0.69 (0.45, 4.14) | 0.635 | 0.80 (0.51, 6.27) | 0.48 (0.28, 2.81) | 0.171 |
PC(18:1(11Z)/15:0) | 0.17 (0.11, 0.42) | 0.243 (0.12, 0.71) | 0.455 | 0.19 (0.07, 0.38) | 0.13 (0.08, 0.54) | 0.673 |
PC(18:3(6Z,9Z,12Z)/18:0) | 1.20 (0.79, 5.02) | 0.91 (0.72, 3.39) | 0.667 | 1.38 (0.54, 9.41) | 0.83 (0.46, 6.06) | 0461 |
PC(20:2(11Z, 14Z)/14:0) | 9.10 (3.79, 28.02) | 4.67 (2.63, 35.09) | 0.635 | 11.34 (2.10, 72.33) | 2.98 (1.68, 29.94) | 0.246 |